Biotechnology
The Biotechnology industry has a total of 660 stocks, with a combined market cap of $836.45 billion and total revenue of $94.85 billion.
Market Cap
836.45B
Revenue
94.85B
Profits
-42.58B
PE Ratio
n/a
Profit Margin
-44.89%
Dividend Yield
0.01%
660 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 103.26B | 0.93% | 856,617 | 10.63B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.92B | 1.87% | 355,406 | 13.85B |
| 3 | ARGX | argenx SE | 38.02B | -0.30% | 88,412 | 1.91B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.68B | -3.10% | 343,013 | 2.09B |
| 5 | BNTX | BioNTech SE | 27.25B | 0.51% | 157,293 | 3.39B |
| 6 | BGNE | BeiGene, Ltd. | 18.81B | 0.28% | 131,665 | 3.35B |
| 7 | UTHR | United Therapeutics Corporation | 16.18B | 0.79% | 69,050 | 2.76B |
| 8 | MRNA | Moderna, Inc. | 15.31B | 0.99% | 2,677,919 | 5.08B |
| 9 | RPRX | Royalty Pharma plc | 14.85B | 1.16% | 3,591,963 | 2.27B |
| 10 | SMMT | Summit Therapeutics Inc. | 13.66B | 3.69% | 817,849 | - |
| 11 | INCY | Incyte Corporation | 13.44B | 1.34% | 412,484 | 4.08B |
| 12 | GMAB | Genmab A/S | 12.97B | 1.62% | 709,395 | 2.97B |
| 13 | BMRN | BioMarin Pharmaceutical Inc. | 12.63B | 0.94% | 375,584 | 2.75B |
| 14 | INSM | Insmed Incorporated | 12.46B | -1.12% | 432,236 | 342.96M |
| 15 | TECH | Bio-Techne Corporation | 11.55B | -0.68% | 230,937 | 1.17B |
| 16 | SRPT | Sarepta Therapeutics, Inc. | 11.42B | 0.48% | 203,839 | 1.64B |
| 17 | PCVX | Vaxcyte, Inc. | 10.72B | -0.62% | 243,995 | - |
| 18 | EXEL | Exelixis, Inc. | 9.51B | 0.03% | 687,422 | 2.08B |
| 19 | ROIV | Roivant Sciences Ltd. | 8.60B | 2.16% | 4,691,136 | 129.13M |
| 20 | ASND | Ascendis Pharma A/S | 8.23B | 1.00% | 73,198 | 365.19M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 7.48B | 0.67% | 155,393 | 3.99B |
| 22 | RVMD | Revolution Medicines, Inc. | 7.38B | -0.39% | 277,036 | 742.00K |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.72B | -0.14% | 67,328 | 76.81M |
| 24 | LEGN | Legend Biotech Corporation | 6.15B | -1.69% | 736,656 | 520.18M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 5.97B | - | 537,289 | 947.36M |
| 26 | NUVL | Nuvalent, Inc. | 5.94B | -0.66% | 131,107 | - |
| 27 | CYTK | Cytokinetics, Incorporated | 5.77B | -0.02% | 466,266 | 3.22M |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 5.70B | 1.40% | 715,009 | 803.07M |
| 29 | BPMC | Blueprint Medicines Corporation | 5.65B | -1.40% | 108,200 | 434.42M |
| 30 | CORT | Corcept Therapeutics Incorporated | 5.31B | -1.32% | 297,713 | 628.56M |
| 31 | BBIO | BridgeBio Pharma, Inc. | 5.19B | 3.70% | 580,395 | 217.77M |
| 32 | TLX | Telix Pharmaceuticals Limited | 5.15B | 0.14% | 5,197 | 430.80M |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.98B | 0.25% | 135,917 | 1.04M |
| 34 | VKTX | Viking Therapeutics, Inc. | 4.65B | -1.24% | 1,699,792 | - |
| 35 | KRYS | Krystal Biotech, Inc. | 4.65B | -1.94% | 84,345 | 241.52M |
| 36 | TGTX | TG Therapeutics, Inc. | 4.65B | 0.51% | 468,462 | 264.79M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 4.21B | -4.35% | 438,549 | 338.46M |
| 38 | ADMA | ADMA Biologics, Inc. | 4.17B | 1.44% | 786,878 | 382.81M |
| 39 | SRRK | Scholar Rock Holding Corporation | 4.17B | -0.58% | 321,670 | - |
| 40 | APLS | Apellis Pharmaceuticals, Inc. | 4.13B | - | 442,743 | 715.22M |
| 41 | ACLX | Arcellx, Inc. | 4.07B | -0.40% | 107,496 | 155.82M |
| 42 | RARE | Ultragenyx Pharmaceutical Inc. | 4.03B | -1.31% | 237,205 | 522.75M |
| 43 | IMVT | Immunovant, Inc. | 3.79B | -0.15% | 172,225 | - |
| 44 | RNA | Avidity Biosciences, Inc. | 3.76B | -1.07% | 454,652 | 10.12M |
| 45 | VRNA | Verona Pharma plc | 3.68B | 7.04% | 575,535 | 5.62M |
| 46 | BHVN | Biohaven Ltd. | 3.65B | -0.34% | 299,079 | - |
| 47 | PTCT | PTC Therapeutics, Inc. | 3.49B | -2.17% | 179,413 | 900.66M |
| 48 | CRSP | CRISPR Therapeutics AG | 3.45B | -0.84% | 834,958 | 202.83M |
| 49 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.43B | -0.53% | 622,927 | 112.53M |
| 50 | MLTX | MoonLake Immunotherapeutics | 3.34B | 1.57% | 45,917 | - |
| 51 | DNLI | Denali Therapeutics Inc. | 2.99B | -3.26% | 251,775 | - |
| 52 | MRUS | Merus N.V. | 2.94B | 2.65% | 123,260 | 35.93M |
| 53 | JANX | Janux Therapeutics, Inc. | 2.94B | -1.51% | 145,346 | 13.05M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 2.92B | -0.15% | 630,161 | 493.67M |
| 55 | XENE | Xenon Pharmaceuticals Inc. | 2.92B | -0.88% | 140,292 | - |
| 56 | ZLAB | Zai Lab Limited | 2.87B | -0.71% | 125,756 | 355.75M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 2.87B | -1.64% | 327,944 | - |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 2.84B | 1.01% | 346,363 | 929.24M |
| 59 | VCEL | Vericel Corporation | 2.81B | 0.71% | 81,568 | 226.84M |
| 60 | SWTX | SpringWorks Therapeutics, Inc. | 2.73B | 3.27% | 239,871 | 135.49M |
| 61 | VERA | Vera Therapeutics, Inc. | 2.69B | -0.36% | 127,344 | - |
| 62 | APGE | Apogee Therapeutics, Inc. | 2.69B | -1.07% | 99,925 | - |
| 63 | KYMR | Kymera Therapeutics, Inc. | 2.62B | -0.59% | 77,701 | 87.56M |
| 64 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.56B | 0.85% | 232,169 | 460.48M |
| 65 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.45B | 1.08% | 486,023 | 3.55M |
| 66 | PTGX | Protagonist Therapeutics, Inc. | 2.44B | -1.42% | 284,756 | 323.80M |
| 67 | DYN | Dyne Therapeutics, Inc. | 2.42B | -0.92% | 197,956 | - |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 2.36B | 0.27% | 171,417 | 33.59M |
| 69 | BEAM | Beam Therapeutics Inc. | 2.29B | -0.75% | 288,872 | 349.64M |
| 70 | CNTA | Centessa Pharmaceuticals plc | 2.27B | 0.29% | 186,523 | 6.85M |
| 71 | IOVA | Iovance Biotherapeutics, Inc. | 2.26B | 0.34% | 3,390,567 | 90.86M |
| 72 | LGND | Ligand Pharmaceuticals Incorporated | 2.19B | 0.94% | 26,179 | 152.42M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.18B | -1.33% | 327,277 | 3.92M |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 2.06B | 1.61% | 173,574 | 129.62M |
| 75 | WVE | Wave Life Sciences Ltd. | 2.03B | -1.70% | 465,585 | 53.61M |
| 76 | GERN | Geron Corporation | 2.01B | -4.73% | 5,651,360 | 29.48M |
| 77 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | -0.76% | 344,465 | 32.87M |
| 78 | MIRM | Mirum Pharmaceuticals, Inc. | 2.00B | 0.49% | 103,079 | 307.03M |
| 79 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | 1.25% | 161,021 | 681.88M |
| 80 | AKRO | Akero Therapeutics, Inc. | 1.97B | -3.71% | 278,845 | - |
| 81 | BLTE | Belite Bio, Inc | 1.95B | -1.75% | 15,742 | - |
| 82 | SLNO | Soleno Therapeutics, Inc. | 1.91B | -1.82% | 141,303 | - |
| 83 | MNKD | MannKind Corporation | 1.91B | 0.88% | 1,074,121 | 267.20M |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 1.89B | 9.37% | 11,173,524 | 65.18M |
| 85 | CGON | CG Oncology, Inc. | 1.88B | -2.96% | 144,580 | 684.00K |
| 86 | IRON | Disc Medicine, Inc. | 1.86B | -2.91% | 96,418 | - |
| 87 | IBRX | ImmunityBio, Inc. | 1.83B | - | 1,702,115 | 7.33M |
| 88 | MESO | Mesoblast Limited | 1.81B | 10.18% | 646,688 | 5.90M |
| 89 | NMRA | Neumora Therapeutics, Inc. | 1.80B | 2.67% | 428,311 | - |
| 90 | ARQT | Arcutis Biotherapeutics, Inc. | 1.78B | 1.73% | 1,461,260 | 138.71M |
| 91 | GLPG | Galapagos NV | 1.76B | 0.78% | 129,000 | 290.09M |
| 92 | XNCR | Xencor, Inc. | 1.68B | -0.54% | 216,931 | 85.16M |
| 93 | FTRE | Fortrea Holdings Inc. | 1.67B | -3.40% | 292,087 | 2.98B |
| 94 | GPCR | Structure Therapeutics Inc. | 1.62B | 1.34% | 432,943 | - |
| 95 | CLDX | Celldex Therapeutics, Inc. | 1.61B | -3.58% | 397,884 | 9.98M |
| 96 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.58B | 0.73% | 623,199 | 412.58M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 1.54B | 2.47% | 317,921 | 302.00K |
| 98 | TVTX | Travere Therapeutics, Inc. | 1.47B | -1.60% | 453,138 | 203.45M |
| 99 | IMCR | Immunocore Holdings plc | 1.41B | -0.39% | 94,875 | 296.31M |
| 100 | RCUS | Arcus Biosciences, Inc. | 1.41B | -0.52% | 177,775 | 263.00M |
| 101 | PRAX | Praxis Precision Medicines, Inc. | 1.40B | -1.86% | 83,666 | 1.61M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.40B | -0.55% | 132,792 | 56.42M |
| 103 | NVAX | Novavax, Inc. | 1.37B | -1.61% | 1,035,661 | 885.19M |
| 104 | SYRE | Spyre Therapeutics, Inc. | 1.37B | -2.47% | 119,722 | - |
| 105 | MDXG | MiMedx Group, Inc. | 1.36B | 1.43% | 184,221 | 342.80M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 1.33B | -0.47% | 174,014 | 61.44M |
| 107 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.31B | -3.72% | 752,312 | 276.92M |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 1.29B | -0.50% | 468,056 | 220.36M |
| 109 | DAWN | Day One Biopharmaceuticals, Inc. | 1.26B | -2.15% | 269,916 | 101.95M |
| 110 | SEPN | Septerna, Inc. | 1.23B | 14.21% | 140,767 | 981.00K |
| 111 | ARVN | Arvinas, Inc. | 1.23B | -3.36% | 254,181 | 161.10M |
| 112 | NTLA | Intellia Therapeutics, Inc. | 1.23B | -1.24% | 950,456 | 43.09M |
| 113 | INVA | Innoviva, Inc. | 1.11B | -0.22% | 175,265 | 352.75M |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.11B | -0.31% | 2,202,002 | 16.00M |
| 115 | ELVN | Enliven Therapeutics, Inc. | 1.11B | 1.07% | 85,695 | - |
| 116 | ARDX | Ardelyx, Inc. | 1.11B | -3.12% | 1,379,961 | 251.85M |
| 117 | GYRE | Gyre Therapeutics, Inc. | 1.06B | 11.13% | 67,298 | 105.03M |
| 118 | SPRY | ARS Pharmaceuticals, Inc. | 1.06B | -2.55% | 412,440 | 2.57M |
| 119 | PHVS | Pharvaris N.V. | 1.04B | -2.15% | 20,411 | - |
| 120 | RCKT | Rocket Pharmaceuticals, Inc. | 1.03B | -1.81% | 469,095 | - |
| 121 | BCAX | Bicara Therapeutics Inc. | 1.02B | 6.61% | 150,213 | - |
| 122 | VIR | Vir Biotechnology, Inc. | 1.01B | 0.14% | 307,850 | 78.62M |
| 123 | BCYC | Bicycle Therapeutics plc | 1.01B | -0.31% | 238,781 | 36.90M |
| 124 | ZYME | Zymeworks Inc. | 964.29M | -0.99% | 117,985 | 62.20M |
| 125 | LQDA | Liquidia Corporation | 957.24M | 1.89% | 215,470 | 15.61M |
| 126 | UPB | Upstream Bio, Inc. | 948.12M | 9.13% | 104,347 | 2.21M |
| 127 | REPL | Replimune Group, Inc. | 936.48M | -0.48% | 262,076 | - |
| 128 | ETNB | 89bio, Inc. | 934.19M | 0.06% | 576,178 | - |
| 129 | AVXL | Anavex Life Sciences Corp. | 929.36M | 27.00% | 5,477,297 | - |
| 130 | ADPT | Adaptive Biotechnologies Corporation | 923.11M | -2.11% | 265,531 | 177.28M |
| 131 | PSTX | Poseida Therapeutics, Inc. | 920.09M | -0.11% | 383,006 | 150.86M |
| 132 | NUVB | Nuvation Bio Inc. | 883.49M | -2.05% | 1,433,787 | 2.16M |
| 133 | AVBP | ArriVent BioPharma, Inc. | 880.51M | 0.15% | 69,215 | - |
| 134 | ABCL | AbCellera Biologics Inc. | 856.56M | 1.76% | 1,307,713 | 32.96M |
| 135 | QURE | uniQure N.V. | 850.57M | 2.77% | 475,005 | 28.59M |
| 136 | LENZ | LENZ Therapeutics, Inc. | 839.88M | -6.40% | 62,079 | - |
| 137 | COGT | Cogent Biosciences, Inc. | 834.54M | -3.64% | 600,412 | - |
| 138 | IMTX | Immatics N.V. | 834.30M | 2.04% | 211,598 | 128.82M |
| 139 | PRTA | Prothena Corporation plc | 824.89M | 0.72% | 209,110 | 133.35M |
| 140 | PLRX | Pliant Therapeutics, Inc. | 794.14M | -1.21% | 204,249 | - |
| 141 | CDMO | Avid Bioservices, Inc. | 785.79M | -0.12% | 320,803 | 150.45M |
| 142 | TYRA | Tyra Biosciences, Inc. | 734.87M | -0.21% | 75,705 | - |
| 143 | RLAY | Relay Therapeutics, Inc. | 723.93M | 3.97% | 946,274 | 10.01M |
| 144 | OCS | Oculis Holding AG | 705.10M | -1.00% | 19,854 | 1.03M |
| 145 | TECX | Tectonic Therapeutic, Inc. | 701.05M | 0.17% | 14,120 | - |
| 146 | ERAS | Erasca, Inc. | 695.23M | -3.20% | 403,829 | - |
| 147 | KURA | Kura Oncology, Inc. | 692.10M | -1.22% | 539,061 | - |
| 148 | DNTH | Dianthus Therapeutics, Inc. | 686.65M | -2.53% | 72,267 | 5.37M |
| 149 | KROS | Keros Therapeutics, Inc. | 686.20M | -0.53% | 415,867 | 651.00K |
| 150 | IMNM | Immunome, Inc. | 685.34M | 0.09% | 246,698 | 10.13M |
| 151 | SVRA | Savara Inc. | 674.46M | -0.31% | 788,030 | - |
| 152 | CGEM | Cullinan Therapeutics, Inc. | 667.87M | -1.12% | 176,296 | - |
| 153 | MBX | MBX Biosciences, Inc. | 665.67M | -2.16% | 61,618 | - |
| 154 | CRGX | CARGO Therapeutics, Inc. | 665.56M | -2.95% | 77,102 | - |
| 155 | RAPP | Rapport Therapeutics, Inc. | 659.47M | -0.22% | 14,573 | - |
| 156 | CVAC | CureVac N.V. | 654.17M | 1.61% | 294,340 | 70.57M |
| 157 | PHAR | Pharming Group N.V. | 622.18M | 0.96% | 2,809 | 285.75M |
| 158 | CAPR | Capricor Therapeutics, Inc. | 618.62M | 4.08% | 577,879 | 23.23M |
| 159 | TRDA | Entrada Therapeutics, Inc. | 613.93M | -1.42% | 33,671 | 215.23M |
| 160 | OMER | Omeros Corporation | 613.69M | 2.72% | 595,921 | - |
| 161 | STOK | Stoke Therapeutics, Inc. | 613.36M | -0.86% | 152,538 | 16.74M |
| 162 | ABUS | Arbutus Biopharma Corporation | 605.43M | -0.47% | 213,074 | 6.74M |
| 163 | MLYS | Mineralys Therapeutics, Inc. | 593.24M | -3.39% | 176,859 | - |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 587.82M | 1.46% | 144,975 | - |
| 165 | HUMA | Humacyte, Inc. | 586.08M | -1.83% | 8,917,351 | - |
| 166 | AUTL | Autolus Therapeutics plc | 585.71M | -3.88% | 1,318,956 | 10.09M |
| 167 | OPT | Opthea Limited | 558.15M | 3.28% | 5,079 | 261.86K |
| 168 | ANNX | Annexon, Inc. | 551.09M | -1.15% | 437,471 | - |
| 169 | ALT | Altimmune, Inc. | 549.79M | -6.30% | 1,851,738 | 52.00K |
| 170 | ATXS | Astria Therapeutics, Inc. | 529.64M | -1.83% | 82,305 | - |
| 171 | TRML | Tourmaline Bio, Inc. | 526.96M | -0.48% | 85,466 | - |
| 172 | MNMD | Mind Medicine (MindMed) Inc. | 515.52M | -1.82% | 462,858 | - |
| 173 | EYPT | EyePoint Pharmaceuticals, Inc. | 511.29M | 2.64% | 237,272 | 45.71M |
| 174 | MREO | Mereo BioPharma Group plc | 511.16M | -1.49% | 286,022 | 1.00M |
| 175 | CRMD | CorMedix Inc. | 507.87M | -2.33% | 321,878 | 12.26M |
| 176 | VERV | Verve Therapeutics, Inc. | 506.29M | 4.18% | 669,747 | 24.40M |
| 177 | SGMO | Sangamo Therapeutics, Inc. | 505.97M | -1.82% | 3,569,600 | 52.29M |
| 178 | XERS | Xeris Biopharma Holdings, Inc. | 498.68M | -4.16% | 833,438 | 187.36M |
| 179 | DNA | Ginkgo Bioworks Holdings, Inc. | 497.91M | -6.94% | 1,174,159 | 217.95M |
| 180 | RNAC | Cartesian Therapeutics, Inc. | 495.17M | 1.20% | 23,957 | 47.94M |
| 181 | TERN | Terns Pharmaceuticals, Inc. | 490.95M | -1.37% | 505,907 | - |
| 182 | PHAT | Phathom Pharmaceuticals, Inc. | 486.50M | -4.49% | 418,650 | 26.27M |
| 183 | KOD | Kodiak Sciences Inc. | 486.43M | 7.11% | 239,544 | - |
| 184 | PROK | ProKidney Corp. | 485.62M | 10.26% | 338,516 | - |
| 185 | THRD | Third Harmonic Bio, Inc. | 482.58M | -1.20% | 26,342 | - |
| 186 | TBPH | Theravance Biopharma, Inc. | 479.45M | 1.67% | 75,611 | 63.19M |
| 187 | ALMS | Alumis Inc. | 473.34M | -1.36% | 68,347 | - |
| 188 | MGTX | MeiraGTx Holdings plc | 468.06M | -2.62% | 75,512 | 13.93M |
| 189 | ABVX | ABIVAX Société Anonyme | 465.79M | -4.55% | 271,081 | 9.68M |
| 190 | PRTC | PureTech Health plc | 465.36M | -0.94% | 463 | 468.00K |
| 191 | CELC | Celcuity Inc. | 452.61M | -2.17% | 101,028 | - |
| 192 | ZVRA | Zevra Therapeutics, Inc. | 447.29M | -1.30% | 191,602 | 24.49M |
| 193 | URGN | UroGen Pharma Ltd. | 445.63M | -0.75% | 182,194 | 89.36M |
| 194 | ANAB | AnaptysBio, Inc. | 436.20M | -1.47% | 208,824 | 57.17M |
| 195 | ARCT | Arcturus Therapeutics Holdings Inc. | 435.91M | 3.95% | 203,926 | 160.40M |
| 196 | GLUE | Monte Rosa Therapeutics, Inc. | 429.13M | 0.79% | 541,992 | 14.98M |
| 197 | OABI | OmniAb, Inc. | 422.03M | -0.36% | 120,917 | 20.41M |
| 198 | ZBIO | Zenas BioPharma, Inc. | 414.98M | -0.80% | 205,069 | - |
| 199 | KALV | KalVista Pharmaceuticals, Inc. | 413.63M | 0.12% | 117,515 | - |
| 200 | KRRO | Korro Bio, Inc. | 408.83M | -0.07% | 16,647 | - |
| 201 | AURA | Aura Biosciences, Inc. | 406.60M | -0.73% | 55,474 | - |
| 202 | ALLO | Allogene Therapeutics, Inc. | 402.57M | 2.67% | 1,678,534 | 43.00K |
| 203 | CDXS | Codexis, Inc. | 394.28M | -8.23% | 323,486 | 64.45M |
| 204 | IGMS | IGM Biosciences, Inc. | 385.33M | -6.09% | 155,278 | 2.92M |
| 205 | TSHA | Taysha Gene Therapies, Inc. | 375.05M | -1.08% | 413,798 | 9.92M |
| 206 | OLMA | Olema Pharmaceuticals, Inc. | 374.46M | 7.21% | 321,683 | - |
| 207 | GHRS | GH Research PLC | 364.20M | 2.19% | 43,984 | - |
| 208 | RGNX | REGENXBIO Inc. | 363.98M | -3.60% | 860,420 | 84.33M |
| 209 | YMAB | Y-mAbs Therapeutics, Inc. | 361.90M | -2.42% | 112,337 | 84.55M |
| 210 | PRME | Prime Medicine, Inc. | 361.73M | -2.24% | 522,993 | 800.00K |
| 211 | CTNM | Contineum Therapeutics, Inc. | 358.57M | 3.04% | 25,296 | - |
| 212 | SANA | Sana Biotechnology, Inc. | 353.88M | -3.94% | 900,382 | - |
| 213 | DSGN | Design Therapeutics, Inc. | 352.75M | -0.32% | 59,013 | - |
| 214 | TNGX | Tango Therapeutics, Inc. | 341.59M | 2.58% | 368,760 | 43.38M |
| 215 | SAGE | Sage Therapeutics, Inc. | 341.35M | -0.53% | 330,062 | 106.40M |
| 216 | ABSI | Absci Corporation | 331.93M | -3.35% | 807,238 | 4.21M |
| 217 | NGNE | Neurogene Inc. | 329.05M | -1.99% | 85,559 | 925.00K |
| 218 | JSPR | Jasper Therapeutics, Inc. | 326.05M | 0.77% | 68,738 | - |
| 219 | VALN | Valneva SE | 325.42M | -0.75% | 26,746 | 176.82M |
| 220 | XOMA | XOMA Royalty Corporation | 323.67M | 1.25% | 8,547 | 21.61M |
| 221 | RVNC | Revance Therapeutics, Inc. | 323.10M | -0.32% | 945,470 | 256.95M |
| 222 | SLRN | Acelyrin, Inc. | 320.04M | 1.27% | 275,427 | - |
| 223 | SLN | Silence Therapeutics plc | 316.58M | -2.54% | 172,222 | 21.77M |
| 224 | VYGR | Voyager Therapeutics, Inc. | 313.55M | -0.17% | 157,284 | 163.78M |
| 225 | TRVI | Trevi Therapeutics, Inc. | 310.92M | -0.12% | 490,470 | - |
| 226 | ENGN | enGene Holdings Inc. | 310.76M | 4.57% | 105,105 | - |
| 227 | IMMP | Immutep Limited | 309.27M | -3.04% | 123,531 | 2.56M |
| 228 | CRVS | Corvus Pharmaceuticals, Inc. | 302.65M | -5.61% | 679,840 | - |
| 229 | RIGL | Rigel Pharmaceuticals, Inc. | 297.28M | -1.25% | 64,347 | 157.37M |
| 230 | CCCC | C4 Therapeutics, Inc. | 290.12M | 4.05% | 497,017 | 33.67M |
| 231 | ALDX | Aldeyra Therapeutics, Inc. | 282.56M | -2.76% | 112,522 | - |
| 232 | ATYR | aTyr Pharma, Inc. | 277.85M | -1.19% | 456,346 | 235.00K |
| 233 | AVIR | Atea Pharmaceuticals, Inc. | 277.82M | 3.11% | 99,317 | - |
| 234 | AMLX | Amylyx Pharmaceuticals, Inc. | 276.50M | 0.28% | 114,460 | 196.49M |
| 235 | CADL | Candel Therapeutics, Inc. | 276.06M | -2.85% | 1,972,775 | - |
| 236 | FHTX | Foghorn Therapeutics Inc. | 276.02M | -3.40% | 87,061 | 25.52M |
| 237 | FDMT | 4D Molecular Therapeutics, Inc. | 275.05M | -5.71% | 388,738 | 17.00K |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 272.01M | -2.41% | 422,700 | 190.86M |
| 239 | PRQR | ProQR Therapeutics N.V. | 271.94M | 0.19% | 107,559 | 20.51M |
| 240 | CMRX | Chimerix, Inc. | 269.81M | 0.33% | 699,289 | 159.00K |
| 241 | ACIU | AC Immune SA | 269.37M | 1.59% | 62,804 | 48.51M |
| 242 | ITOS | iTeos Therapeutics, Inc. | 266.70M | -1.62% | 191,342 | 35.00M |
| 243 | LXRX | Lexicon Pharmaceuticals, Inc. | 265.88M | 2.91% | 4,124,410 | 5.23M |
| 244 | DRUG | Bright Minds Biosciences Inc. | 263.68M | -0.39% | 25,053 | - |
| 245 | ARTV | Artiva Biotherapeutics, Inc. | 256.74M | -4.86% | 26,743 | 2.60M |
| 246 | BNTC | Benitec Biopharma Inc. | 255.85M | -3.42% | 121,674 | - |
| 247 | CDTX | Cidara Therapeutics, Inc. | 253.24M | -0.30% | 26,340 | 44.65M |
| 248 | RZLT | Rezolute, Inc. | 252.63M | -0.68% | 142,291 | - |
| 249 | LRMR | Larimar Therapeutics, Inc. | 250.44M | -2.12% | 337,428 | - |
| 250 | ABEO | Abeona Therapeutics Inc. | 245.61M | -0.88% | 92,827 | - |
| 251 | ELDN | Eledon Pharmaceuticals, Inc. | 244.93M | -5.96% | 232,139 | - |
| 252 | HRTX | Heron Therapeutics, Inc. | 244.11M | 1.58% | 802,871 | 137.74M |
| 253 | FULC | Fulcrum Therapeutics, Inc. | 242.72M | 3.45% | 741,843 | 80.87M |
| 254 | ZNTL | Zentalis Pharmaceuticals, Inc. | 230.19M | 7.67% | 403,447 | 40.56M |
| 255 | DMAC | DiaMedica Therapeutics Inc. | 222.78M | -18.72% | 126,933 | - |
| 256 | PGEN | Precigen, Inc. | 219.89M | -1.55% | 650,042 | 3.96M |
| 257 | BIOA | BioAge Labs, Inc. | 215.63M | -2.04% | 776,164 | - |
| 258 | OCGN | Ocugen, Inc. | 214.18M | -5.04% | 4,798,531 | 4.70M |
| 259 | DRTS | Alpha Tau Medical Ltd. | 213.62M | -1.13% | 63,005 | - |
| 260 | NAUT | Nautilus Biotechnology, Inc. | 212.20M | -3.98% | 140,924 | - |
| 261 | INBX | Inhibrx Biosciences, Inc. | 210.33M | -0.48% | 26,072 | 1.57M |
| 262 | RENB | Renovaro Inc. | 210.30M | -19.21% | 661,650 | - |
| 263 | CRDF | Cardiff Oncology, Inc. | 209.90M | -3.64% | 832,724 | 688.00K |
| 264 | CMPX | Compass Therapeutics, Inc. | 207.76M | 9.43% | 234,808 | 850.00K |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 207.65M | - | 51,753 | - |
| 266 | IVA | Inventiva S.A. | 203.71M | -6.47% | 7,689 | 20.65M |
| 267 | MGNX | MacroGenics, Inc. | 203.04M | 1.73% | 220,688 | 141.33M |
| 268 | ATAI | Atai Life Sciences N.V. | 200.49M | 0.40% | 862,003 | 331.00K |
| 269 | ACRV | Acrivon Therapeutics, Inc. | 199.12M | -4.69% | 35,710 | - |
| 270 | IKT | Inhibikase Therapeutics, Inc. | 197.88M | -7.97% | 111,824 | 1.00 |
| 271 | GOSS | Gossamer Bio, Inc. | 190.91M | 0.30% | 441,922 | 105.32M |
| 272 | ADCT | ADC Therapeutics SA | 190.48M | 0.51% | 528,291 | 70.72M |
| 273 | CYBN | Cybin Inc. | 190.01M | -1.14% | 80,622 | - |
| 274 | FATE | Fate Therapeutics, Inc. | 187.72M | -1.90% | 1,548,821 | 13.45M |
| 275 | MDWD | MediWound Ltd. | 187.21M | 5.22% | 26,518 | 19.72M |
| 276 | ALEC | Alector, Inc. | 182.15M | - | 427,703 | 61.51M |
| 277 | INZY | Inozyme Pharma, Inc. | 181.80M | -5.18% | 173,469 | - |
| 278 | GNFT | Genfit S.A. | 179.71M | -1.18% | 1,570 | 86.23M |
| 279 | MRSN | Mersana Therapeutics, Inc. | 179.12M | -9.38% | 462,229 | 34.84M |
| 280 | TVGN | Tevogen Bio Holdings Inc. | 178.55M | 2.41% | 618,284 | - |
| 281 | VSTM | Verastem, Inc. | 178.25M | -4.42% | 287,206 | 10.00M |
| 282 | MOLN | Molecular Partners AG | 175.65M | -1.93% | 17,381 | 7.11M |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 175.43M | -6.20% | 25,441 | 2.65M |
| 284 | LYEL | Lyell Immunopharma, Inc. | 175.18M | 2.40% | 427,038 | 63.00K |
| 285 | HURA | TuHURA Biosciences, Inc. | 173.16M | -8.04% | 83,340 | - |
| 286 | FENC | Fennec Pharmaceuticals Inc. | 171.56M | 4.43% | 56,653 | 49.35M |
| 287 | KYTX | Kyverna Therapeutics, Inc. | 169.66M | -1.75% | 71,343 | - |
| 288 | SCPH | scPharmaceuticals Inc. | 169.64M | - | 256,606 | 30.28M |
| 289 | CKPT | Checkpoint Therapeutics, Inc. | 169.20M | -7.61% | 1,048,287 | 47.00K |
| 290 | NKTX | Nkarta, Inc. | 169.01M | 1.05% | 1,275,052 | - |
| 291 | NKTR | Nektar Therapeutics | 168.48M | -1.60% | 934,868 | 93.14M |
| 292 | TCRX | TScan Therapeutics, Inc. | 167.82M | - | 128,913 | 9.36M |
| 293 | MCRB | Seres Therapeutics, Inc. | 165.89M | 6.13% | 1,473,544 | 126.33M |
| 294 | CHRS | Coherus BioSciences, Inc. | 164.76M | -5.94% | 1,511,459 | 304.34M |
| 295 | SLDB | Solid Biosciences Inc. | 162.82M | -2.04% | 287,695 | - |
| 296 | IPHA | Innate Pharma S.A. | 162.24M | 1.95% | 21,961 | 36.20M |
| 297 | VTYX | Ventyx Biosciences, Inc. | 160.87M | 1.56% | 648,009 | - |
| 298 | CRBU | Caribou Biosciences, Inc. | 160.73M | -1.39% | 707,903 | 11.48M |
| 299 | GLSI | Greenwich LifeSciences, Inc. | 158.39M | -2.73% | 14,257 | - |
| 300 | NBTX | Nanobiotix S.A. | 158.11M | -1.45% | 37,169 | 45.22M |
| 301 | SGMT | Sagimet Biosciences Inc. | 156.79M | -1.62% | 182,164 | - |
| 302 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 155.90M | -1.54% | 103,923 | - |
| 303 | CLLS | Cellectis S.A. | 155.56M | -2.52% | 12,229 | 36.04M |
| 304 | STRO | Sutro Biopharma, Inc. | 155.43M | 0.27% | 340,034 | 160.96M |
| 305 | ZURA | Zura Bio Limited | 155.07M | 4.16% | 682,583 | - |
| 306 | MGX | Metagenomi, Inc. | 151.19M | -0.25% | 935,964 | 55.08M |
| 307 | ADAP | Adaptimmune Therapeutics plc | 150.15M | -2.99% | 1,497,851 | 175.04M |
| 308 | TSVT | 2seventy bio, Inc. | 149.35M | -7.80% | 188,855 | 45.62M |
| 309 | ALGS | Aligos Therapeutics, Inc. | 147.83M | -0.03% | 243,561 | 6.00M |
| 310 | BMEA | Biomea Fusion, Inc. | 147.49M | -3.78% | 250,750 | - |
| 311 | IFRX | InflaRx N.V. | 143.09M | 8.48% | 96,259 | 187.93K |
| 312 | XBIT | XBiotech Inc. | 141.07M | -27.47% | 396,698 | - |
| 313 | TIL | Instil Bio, Inc. | 138.25M | 2.79% | 62,167 | - |
| 314 | TELO | Telomir Pharmaceuticals, Inc. | 137.69M | -10.23% | 102,838 | - |
| 315 | VXRT | Vaxart, Inc. | 137.51M | -2.44% | 780,139 | 16.76M |
| 316 | PBYI | Puma Biotechnology, Inc. | 136.71M | 1.27% | 168,811 | 243.57M |
| 317 | SEER | Seer, Inc. | 135.33M | -0.65% | 73,217 | 14.61M |
| 318 | MNPR | Monopar Therapeutics Inc. | 134.71M | -1.15% | 15,531 | - |
| 319 | ENTA | Enanta Pharmaceuticals, Inc. | 134.19M | 0.82% | 196,271 | 67.64M |
| 320 | CGEN | Compugen Ltd. | 133.41M | -2.61% | 282,272 | 59.85M |
| 321 | CLYM | Climb Bio, Inc. | 130.41M | -0.51% | 577,395 | - |
| 322 | ATOS | Atossa Therapeutics, Inc. | 129.58M | 6.88% | 628,908 | - |
| 323 | ACTU | Actuate Therapeutics, Inc. | 129.30M | -2.22% | 54,400 | - |
| 324 | PLX | Protalix BioTherapeutics, Inc. | 128.86M | -0.57% | 5,392 | 45.67M |
| 325 | ACHV | Achieve Life Sciences, Inc. | 128.62M | 1.36% | 134,949 | - |
| 326 | TNYA | Tenaya Therapeutics, Inc. | 128.47M | -2.89% | 5,459,093 | - |
| 327 | PEPG | PepGen Inc. | 124.52M | 5.23% | 42,364 | - |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 123.92M | -1.35% | 261,192 | - |
| 329 | CAMP | Camp4 Therapeutics Corporation | 123.79M | 18.08% | 75,530 | - |
| 330 | MIST | Milestone Pharmaceuticals Inc. | 121.22M | 1.67% | 181,532 | - |
| 331 | LCTX | Lineage Cell Therapeutics, Inc. | 117.64M | -4.34% | 693,917 | 8.72M |
| 332 | CABA | Cabaletta Bio, Inc. | 117.06M | 0.63% | 688,063 | - |
| 333 | ABP | Abpro Holdings, Inc. | 116.71M | 11.59% | 861,761 | 122.00K |
| 334 | SAVA | Cassava Sciences, Inc. | 115.94M | 2.55% | 3,388,744 | - |
| 335 | CSBR | Champions Oncology, Inc. | 114.80M | 11.66% | 137,174 | 53.57M |
| 336 | ALLK | Allakos Inc. | 114.37M | 6.65% | 146,104 | - |
| 337 | XFOR | X4 Pharmaceuticals, Inc. | 108.23M | 3.81% | 895,866 | 1.12M |
| 338 | ANRO | Alto Neuroscience, Inc. | 108.15M | 3.08% | 79,058 | - |
| 339 | ABOS | Acumen Pharmaceuticals, Inc. | 107.54M | -3.24% | 359,847 | - |
| 340 | EPRX | Eupraxia Pharmaceuticals Inc. | 107.32M | -1.27% | 3,543 | - |
| 341 | LPTX | Leap Therapeutics, Inc. | 105.95M | -4.98% | 102,382 | - |
| 342 | TARA | Protara Therapeutics, Inc. | 105.93M | -4.74% | 310,773 | - |
| 343 | EDIT | Editas Medicine, Inc. | 104.84M | -3.08% | 1,466,022 | 61.76M |
| 344 | OKUR | OnKure Therapeutics, Inc. | 104.18M | -6.80% | 323,919 | - |
| 345 | MNOV | MediciNova, Inc. | 103.98M | -2.30% | 48,956 | - |
| 346 | ALXO | ALX Oncology Holdings Inc. | 101.00M | 18.21% | 1,285,357 | - |
| 347 | INMB | INmune Bio, Inc. | 98.54M | 1.00% | 119,596 | 42.00K |
| 348 | PYXS | Pyxis Oncology, Inc. | 97.82M | -2.65% | 455,021 | 16.15M |
| 349 | RGLS | Regulus Therapeutics Inc. | 97.60M | -6.27% | 248,016 | - |
| 350 | ADVM | Adverum Biotechnologies, Inc. | 97.36M | -1.27% | 63,403 | 1.00M |
| 351 | IMUX | Immunic, Inc. | 96.83M | 7.48% | 548,085 | - |
| 352 | ASMB | Assembly Biosciences, Inc. | 95.92M | -0.79% | 8,806 | 28.33M |
| 353 | ORMP | Oramed Pharmaceuticals Inc. | 94.93M | -0.63% | 138,134 | - |
| 354 | APLT | Applied Therapeutics, Inc. | 94.83M | -7.41% | 4,395,099 | -212.00K |
| 355 | VERU | Veru Inc. | 94.30M | -0.76% | 1,090,443 | 16.89M |
| 356 | AVTX | Avalo Therapeutics, Inc. | 93.87M | 0.70% | 113,704 | 820.00K |
| 357 | NVCT | Nuvectis Pharma, Inc. | 91.77M | 5.09% | 73,215 | - |
| 358 | GNTA | Genenta Science S.p.A. | 90.66M | -1.06% | 11,613 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 90.05M | 2.86% | 8,670 | 9.55M |
| 360 | HLVX | HilleVax, Inc. | 89.47M | -0.27% | 147,356 | - |
| 361 | GUTS | Fractyl Health, Inc. | 88.98M | 3.35% | 129,487 | 97.00K |
| 362 | IPSC | Century Therapeutics, Inc. | 87.58M | -6.36% | 307,867 | 2.68M |
| 363 | CTMX | CytomX Therapeutics, Inc. | 85.69M | 0.46% | 611,518 | 126.62M |
| 364 | IKNA | Ikena Oncology, Inc. | 84.93M | 13.55% | 3,413,059 | 659.00K |
| 365 | OSTX | OS Therapies Incorporated | 84.32M | 1.53% | 61,400 | - |
| 366 | ANIX | Anixa Biosciences, Inc. | 83.04M | -4.07% | 58,837 | - |
| 367 | ADAG | Adagene Inc. | 81.90M | -5.13% | 51,069 | 815.75K |
| 368 | CBUS | Cibus, Inc. | 81.02M | 3.59% | 157,500 | 4.15M |
| 369 | RANI | Rani Therapeutics Holdings, Inc. | 80.74M | 0.43% | 282,500 | - |
| 370 | IMAB | I-Mab | 80.67M | 7.24% | 134,480 | 3.31M |
| 371 | THTX | Theratechnologies Inc. | 79.98M | 1.12% | 291,658 | 84.32M |
| 372 | ANL | Adlai Nortye Ltd. | 79.03M | -5.66% | 6,181 | 5.00M |
| 373 | SKYE | Skye Bioscience, Inc. | 78.58M | -4.07% | 236,319 | - |
| 374 | KPTI | Karyopharm Therapeutics Inc. | 77.81M | -2.20% | 749,523 | 148.44M |
| 375 | TLSA | Tiziana Life Sciences Ltd | 76.91M | -9.00% | 426,955 | - |
| 376 | GNLX | Genelux Corporation | 76.90M | -0.66% | 60,235 | 8.00K |
| 377 | TNXP | Tonix Pharmaceuticals Holding Corp. | 76.46M | -33.08% | 140,163,126 | 11.29M |
| 378 | GBIO | Generation Bio Co. | 74.81M | -5.83% | 193,053 | 18.58M |
| 379 | QNCX | Quince Therapeutics, Inc. | 74.80M | -4.49% | 111,961 | - |
| 380 | PMVP | PMV Pharmaceuticals, Inc. | 74.52M | -4.00% | 70,558 | - |
| 381 | AVTE | Aerovate Therapeutics, Inc. | 74.50M | 1.98% | 46,044 | - |
| 382 | BLUE | bluebird bio, Inc. | 74.47M | -9.88% | 268,391 | 53.12M |
| 383 | AADI | Aadi Bioscience, Inc. | 73.94M | -11.50% | 770,847 | 25.07M |
| 384 | CNTX | Context Therapeutics Inc. | 73.87M | -3.42% | 15,083,954 | - |
| 385 | FBLG | FibroBiologics, Inc. | 73.48M | -5.78% | 98,943 | - |
| 386 | ACET | Adicet Bio, Inc. | 72.66M | -3.10% | 343,966 | - |
| 387 | EPIX | ESSA Pharma Inc. | 71.91M | 1.25% | 102,050 | - |
| 388 | ENTX | Entera Bio Ltd. | 71.82M | -7.14% | 86,325 | 99.00K |
| 389 | VTGN | Vistagen Therapeutics, Inc. | 71.00M | 1.99% | 395,449 | 876.00K |
| 390 | HOWL | Werewolf Therapeutics, Inc. | 69.52M | -1.89% | 203,922 | 3.39M |
| 391 | VANI | Vivani Medical, Inc. | 69.01M | -1.27% | 56,139 | - |
| 392 | ATRA | Atara Biotherapeutics, Inc. | 68.94M | 5.04% | 92,916 | 100.44M |
| 393 | IMRX | Immuneering Corporation | 68.31M | 10.00% | 471,507 | - |
| 394 | UNCY | Unicycive Therapeutics, Inc. | 68.08M | -4.11% | 852,745 | - |
| 395 | ARMP | Armata Pharmaceuticals, Inc. | 67.99M | -3.64% | 36,325 | 5.47M |
| 396 | BYSI | BeyondSpring Inc. | 67.65M | 5.50% | 18,816 | 1.88M |
| 397 | OVID | Ovid Therapeutics Inc. | 67.36M | -5.05% | 144,613 | 631.70K |
| 398 | CLSD | Clearside Biomedical, Inc. | 67.13M | 1.48% | 194,915 | 7.70M |
| 399 | VIGL | Vigil Neuroscience, Inc. | 65.33M | -5.90% | 256,298 | - |
| 400 | PRLD | Prelude Therapeutics Incorporated | 64.94M | -9.23% | 1,248,759 | 3.00M |
| 401 | AGEN | Agenus Inc. | 64.51M | -2.82% | 282,233 | 160.43M |
| 402 | ONCY | Oncolytics Biotech Inc. | 63.82M | 8.89% | 1,218,115 | - |
| 403 | SLS | SELLAS Life Sciences Group, Inc. | 63.55M | 1.69% | 342,600 | - |
| 404 | VRCA | Verrica Pharmaceuticals Inc. | 63.44M | 0.90% | 259,878 | 9.21M |
| 405 | CUE | Cue Biopharma, Inc. | 63.36M | -0.98% | 110,821 | 9.53M |
| 406 | PDSB | PDS Biotechnology Corporation | 61.73M | 0.01% | 176,219 | - |
| 407 | IMMX | Immix Biopharma, Inc. | 60.52M | 1.38% | 125,483 | - |
| 408 | ANVS | Annovis Bio, Inc. | 60.40M | 0.17% | 139,945 | - |
| 409 | RAPT | RAPT Therapeutics, Inc. | 60.13M | 108.38% | 125,497,431 | - |
| 410 | DBVT | DBV Technologies S.A. | 59.31M | 1.88% | 21,571 | 12.52M |
| 411 | VOR | Vor Biopharma Inc. | 59.27M | -0.48% | 145,011 | - |
| 412 | KRON | Kronos Bio, Inc. | 57.32M | -0.82% | 71,883 | 9.86M |
| 413 | BOLD | Boundless Bio, Inc. | 57.08M | -1.16% | 52,633 | - |
| 414 | RPTX | Repare Therapeutics Inc. | 56.50M | 0.68% | 289,775 | 66.52M |
| 415 | LSB | LakeShore Biopharma Co., Ltd | 56.48M | 0.34% | 22,119 | 79.42M |
| 416 | GALT | Galectin Therapeutics Inc. | 56.14M | -13.99% | 2,192,102 | - |
| 417 | MURA | Mural Oncology plc | 55.85M | 2.83% | 97,435 | - |
| 418 | CNTB | Connect Biopharma Holdings Limited | 55.53M | 5.79% | 3,650 | 24.12M |
| 419 | DYAI | Dyadic International, Inc. | 55.04M | 6.43% | 90,676 | 3.36M |
| 420 | IVVD | Invivyd, Inc. | 54.62M | 2.86% | 571,566 | 11.56M |
| 421 | IOBT | IO Biotech, Inc. | 54.02M | 6.21% | 270,443 | - |
| 422 | ELTX | Elicio Therapeutics, Inc. | 53.89M | 2.46% | 11,687 | - |
| 423 | SER | Serina Therapeutics, Inc. | 53.06M | -5.83% | 19,773 | 3.16M |
| 424 | CELU | Celularity Inc. | 52.39M | - | 96,361 | 48.20M |
| 425 | XLO | Xilio Therapeutics, Inc. | 52.31M | -7.03% | 1,090,597 | 4.62M |
| 426 | STTK | Shattuck Labs, Inc. | 52.27M | -4.78% | 50,295 | 6.44M |
| 427 | SPRO | Spero Therapeutics, Inc. | 51.79M | -0.53% | 175,023 | 106.46M |
| 428 | ALVR | AlloVir, Inc. | 51.38M | 11.11% | 211,340 | - |
| 429 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 49.99M | 11.57% | 3,587,483 | - |
| 430 | MAIA | MAIA Biotechnology, Inc. | 49.90M | -2.48% | 2,177 | - |
| 431 | ITRM | Iterum Therapeutics plc | 49.80M | 2.26% | 219,725 | - |
| 432 | XCUR | Exicure, Inc. | 49.56M | 1.83% | 82,930 | 500.00K |
| 433 | FBIO | Fortress Biotech, Inc. | 47.76M | 0.58% | 281,867 | 81.50M |
| 434 | FGEN | FibroGen, Inc. | 47.12M | 17.21% | 1,506,387 | 180.02M |
| 435 | NTRB | Nutriband Inc. | 47.09M | 3.92% | 5,784 | 2.02M |
| 436 | KZR | Kezar Life Sciences, Inc. | 46.91M | 0.78% | 38,908 | - |
| 437 | INO | Inovio Pharmaceuticals, Inc. | 46.70M | -2.76% | 419,057 | 203.41K |
| 438 | CVM | CEL-SCI Corporation | 45.56M | -2.18% | 409,996 | - |
| 439 | OMGA | Omega Therapeutics, Inc. | 45.40M | -2.02% | 95,773 | 8.10M |
| 440 | BRNS | Barinthus Biotherapeutics plc | 44.85M | 0.45% | 21,351 | 14.97M |
| 441 | VTVT | vTv Therapeutics Inc. | 44.50M | -6.75% | 7,344 | 1.00M |
| 442 | SABS | SAB Biotherapeutics, Inc. | 43.37M | 1.05% | 51,042 | 1.51M |
| 443 | GANX | Gain Therapeutics, Inc. | 42.71M | 3.21% | 51,733 | - |
| 444 | ANTX | AN2 Therapeutics, Inc. | 42.43M | 12.70% | 442,675 | - |
| 445 | CDIO | Cardio Diagnostics Holdings, Inc. | 41.25M | 4.77% | 1,609,544 | 35.69K |
| 446 | PASG | Passage Bio, Inc. | 40.33M | -1.05% | 117,400 | - |
| 447 | ACHL | Achilles Therapeutics plc | 40.32M | - | 18,317 | - |
| 448 | QTTB | Q32 Bio Inc. | 39.95M | -8.61% | 252,116 | -14.66M |
| 449 | ESLA | Estrella Immunopharma, Inc. | 39.80M | -5.11% | 14,780 | - |
| 450 | GRCE | Grace Therapeutics, Inc. | 39.72M | 2.54% | 44,329 | - |
| 451 | ICCC | ImmuCell Corporation | 39.30M | -3.71% | 24,463 | 23.84M |
| 452 | CLGN | CollPlant Biotechnologies Ltd. | 39.06M | -2.29% | 10,198 | 650.00K |
| 453 | CASI | CASI Pharmaceuticals, Inc. | 38.83M | -2.64% | 14,797 | 22.06M |
| 454 | LEXX | Lexaria Bioscience Corp. | 38.74M | -0.45% | 36,871 | 464.28K |
| 455 | TRAW | Traws Pharma, Inc. | 38.58M | 153.98% | 26,419,022 | 226.00K |
| 456 | SRZN | Surrozen, Inc. | 38.51M | 12.16% | 15,249 | 10.00M |
| 457 | ATNM | Actinium Pharmaceuticals, Inc. | 38.37M | -4.65% | 165,257 | 81.00K |
| 458 | VYNE | VYNE Therapeutics Inc. | 38.21M | 3.61% | 195,428 | 493.00K |
| 459 | RLYB | Rallybio Corporation | 37.55M | -4.74% | 131,978 | 598.00K |
| 460 | DTIL | Precision BioSciences, Inc. | 37.51M | 3.57% | 60,250 | 75.10M |
| 461 | ALRN | Aileron Therapeutics, Inc. | 37.37M | -1.42% | 141,744 | - |
| 462 | CALC | CalciMedica, Inc. | 37.34M | 0.36% | 10,694 | - |
| 463 | BIVI | BioVie Inc. | 36.37M | 7.90% | 414,977 | - |
| 464 | OKYO | OKYO Pharma Limited | 36.20M | 0.94% | 10,848 | - |
| 465 | TPST | Tempest Therapeutics, Inc. | 35.21M | 13.36% | 2,375,034 | - |
| 466 | ELEV | Elevation Oncology, Inc. | 34.31M | 0.07% | 635,121 | - |
| 467 | LTRN | Lantern Pharma Inc. | 33.43M | -1.43% | 26,755 | - |
| 468 | OTLK | Outlook Therapeutics, Inc. | 33.12M | -2.78% | 639,871 | - |
| 469 | RADX | Radiopharm Theranostics Limited | 32.61M | -1.57% | 4,900 | 1.31M |
| 470 | BCAB | BioAtla, Inc. | 32.15M | -4.00% | 1,810,804 | 11.00M |
| 471 | IRD | Opus Genetics, Inc. | 32.01M | 3.63% | 105,131 | 8.38M |
| 472 | CMMB | Chemomab Therapeutics Ltd. | 30.50M | -1.98% | 38,076 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 30.43M | -10.26% | 45,169 | 5.40M |
| 474 | MLEC | Moolec Science SA | 30.37M | -8.14% | 81,331 | 5.63M |
| 475 | RNXT | RenovoRx, Inc. | 29.98M | - | 15,864 | - |
| 476 | PMN | ProMIS Neurosciences, Inc. | 29.91M | -1.41% | 7,221 | - |
| 477 | INTS | Intensity Therapeutics, Inc. | 28.84M | 1.58% | 22,257 | - |
| 478 | GDTC | CytoMed Therapeutics Limited | 28.83M | -2.42% | 1,537 | 330.25K |
| 479 | ANEB | Anebulo Pharmaceuticals, Inc. | 28.53M | 11.11% | 477,278 | - |
| 480 | IGC | IGC Pharma, Inc. | 28.35M | -3.43% | 112,152 | 1.18M |
| 481 | CRIS | Curis, Inc. | 27.94M | 7.14% | 75,968 | 10.26M |
| 482 | DARE | Daré Bioscience, Inc. | 27.75M | 17.70% | 87,134 | 1.88M |
| 483 | KALA | KALA BIO, Inc. | 27.30M | 0.04% | 6,258 | - |
| 484 | ENLV | Enlivex Therapeutics Ltd. | 27.05M | -0.81% | 66,339 | - |
| 485 | FBRX | Forte Biosciences, Inc. | 26.90M | -4.85% | 39,724 | - |
| 486 | LVTX | LAVA Therapeutics N.V. | 26.28M | -2.99% | 104,398 | 7.35M |
| 487 | LGVN | Longeveron Inc. | 26.26M | 7.27% | 164,188 | 1.85M |
| 488 | NXTC | NextCure, Inc. | 26.11M | -3.90% | 30,972 | - |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 25.72M | -10.75% | 53,872 | - |
| 490 | CLDI | Calidi Biotherapeutics, Inc. | 25.69M | -2.20% | 186,116 | - |
| 491 | BCTX | BriaCell Therapeutics Corp. | 25.53M | 1.60% | 350,739 | - |
| 492 | CGTX | Cognition Therapeutics, Inc. | 25.34M | -3.19% | 3,073,741 | - |
| 493 | PLUR | Pluri Inc. | 25.14M | -4.19% | 12,346 | 598.00K |
| 494 | PYPD | PolyPid Ltd. | 24.97M | 7.94% | 13,507 | - |
| 495 | LPCN | Lipocine Inc. | 24.76M | -4.93% | 21,320 | 7.92M |
| 496 | COCP | Cocrystal Pharma, Inc. | 24.72M | 8.00% | 108,771 | - |
| 497 | LSTA | Lisata Therapeutics, Inc. | 24.68M | 8.49% | 15,592 | - |
| 498 | NRXS | NeurAxis, Inc. | 24.43M | 12.08% | 24,241 | 2.46M |
| 499 | AEON | AEON Biopharma, Inc. | 24.25M | -6.68% | 36,182 | - |
| 500 | HOOK | HOOKIPA Pharma Inc. | 23.87M | -1.98% | 48,825 | 50.00M |
| 501 | CARA | Cara Therapeutics, Inc. | 23.59M | 1.77% | 1,217,056 | 8.69M |
| 502 | AKTX | Akari Therapeutics, Plc | 23.53M | - | 27,985 | - |
| 503 | BLRX | BioLineRx Ltd. | 22.71M | 4.09% | 1,215,668 | 21.99M |
| 504 | KAPA | Kairos Pharma, Ltd. | 22.63M | 12.31% | 30,133 | - |
| 505 | NKGN | NKGen Biotech, Inc. | 22.55M | -2.09% | 290,957 | - |
| 506 | CTXR | Citius Pharmaceuticals, Inc. | 22.25M | 10.77% | 73,794 | - |
| 507 | IBIO | iBio, Inc. | 22.21M | -2.13% | 22,024 | 175.00K |
| 508 | NNVC | NanoViricides, Inc. | 21.81M | 2.01% | 511,468 | - |
| 509 | OCEA | Ocean Biomedical, Inc. | 21.72M | -6.09% | 343,477 | - |
| 510 | EQ | Equillium, Inc. | 21.61M | 0.33% | 102,965 | 45.91M |
| 511 | NRSN | NeuroSense Therapeutics Ltd. | 21.00M | -22.22% | 1,081,734 | - |
| 512 | INKT | MiNK Therapeutics, Inc. | 20.95M | 1.07% | 78,897 | - |
| 513 | PULM | Pulmatrix, Inc. | 20.93M | -4.50% | 23,993 | 10.01M |
| 514 | GOVX | GeoVax Labs, Inc. | 20.76M | -3.93% | 503,830 | 3.09M |
| 515 | XTLB | XTL Biopharmaceuticals Ltd. | 20.64M | 14.31% | 849 | - |
| 516 | ATHA | Athira Pharma, Inc. | 20.28M | -8.96% | 132,941 | - |
| 517 | ATHE | Alterity Therapeutics Limited | 19.96M | 6.36% | 22,574 | 2.68M |
| 518 | PTN | Palatin Technologies, Inc. | 19.55M | 3.31% | 1,200 | 2.38M |
| 519 | AFMD | Affimed N.V. | 19.26M | -1.26% | 168,067 | 6.29M |
| 520 | TENX | Tenax Therapeutics, Inc. | 19.09M | -0.18% | 2,130 | - |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 18.95M | -0.96% | 188,584 | 9.78M |
| 522 | CRVO | CervoMed Inc. | 18.74M | 1.79% | 211,612 | 10.07M |
| 523 | HCWB | HCW Biologics Inc. | 18.52M | -7.37% | 336,015 | 3.50M |
| 524 | SNTI | Senti Biosciences, Inc. | 18.45M | 1.26% | 67,065 | - |
| 525 | NRXP | NRx Pharmaceuticals, Inc. | 17.43M | -3.67% | 176,309 | - |
| 526 | APTO | Aptose Biosciences Inc. | 17.39M | -12.11% | 6,969,897 | - |
| 527 | INAB | IN8bio, Inc. | 17.25M | -4.26% | 447,548 | - |
| 528 | UBX | Unity Biotechnology, Inc. | 16.97M | 4.92% | 97,891 | - |
| 529 | CARM | Carisma Therapeutics, Inc. | 16.70M | -4.28% | 191,061 | 20.27M |
| 530 | IBO | Impact BioMedical Inc. | 16.45M | -14.37% | 26,731 | - |
| 531 | SYBX | Synlogic, Inc. | 16.27M | -2.04% | 7,232 | 2.78M |
| 532 | BTAI | BioXcel Therapeutics, Inc. | 15.94M | -5.85% | 502,043 | 2.28M |
| 533 | MEIP | MEI Pharma, Inc. | 15.89M | -4.50% | 257,063 | - |
| 534 | APRE | Aprea Therapeutics, Inc. | 15.79M | -4.73% | 19,479 | 1.31M |
| 535 | SPRB | Spruce Biosciences, Inc. | 15.72M | -4.86% | 634,051 | 7.10M |
| 536 | CING | Cingulate Inc. | 15.23M | 15.61% | 222,085 | - |
| 537 | NERV | Minerva Neurosciences, Inc. | 14.90M | -1.39% | 395,988 | - |
| 538 | ACXP | Acurx Pharmaceuticals, Inc. | 14.19M | 1.82% | 19,000 | - |
| 539 | GLYC | GlycoMimetics, Inc. | 13.89M | -7.82% | 196,855 | 10.00K |
| 540 | MTVA | MetaVia Inc. | 13.87M | 0.60% | 62,660 | - |
| 541 | KZIA | Kazia Therapeutics Limited | 13.24M | -0.33% | 12,979 | 1.66M |
| 542 | IPA | ImmunoPrecise Antibodies Ltd. | 13.14M | -2.00% | 542,423 | 17.27M |
| 543 | MRNS | Marinus Pharmaceuticals, Inc. | 12.68M | -0.13% | 543,777 | 31.47M |
| 544 | AIM | AIM ImmunoTech Inc. | 12.43M | 2.58% | 374,748 | 190.00K |
| 545 | ERNA | Eterna Therapeutics Inc. | 12.08M | -6.00% | 127,516 | 598.00K |
| 546 | BCLI | Brainstorm Cell Therapeutics Inc. | 12.02M | -7.55% | 87,460 | - |
| 547 | SLGL | Sol-Gel Technologies Ltd. | 11.84M | -0.93% | 41,420 | 11.71M |
| 548 | LYRA | Lyra Therapeutics, Inc. | 11.45M | -2.83% | 1,043,771 | 1.47M |
| 549 | JAGX | Jaguar Health, Inc. | 11.45M | 4.82% | 311,109 | 10.48M |
| 550 | SNSE | Sensei Biotherapeutics, Inc. | 11.32M | 0.02% | 61,005 | - |
| 551 | IMNN | Imunon, Inc. | 11.31M | -5.97% | 364,576 | - |
| 552 | PMCB | PharmaCyte Biotech, Inc. | 11.25M | -1.58% | 7,088 | - |
| 553 | IMRN | Immuron Limited | 11.18M | - | 4,434 | 3.27M |
| 554 | RLMD | Relmada Therapeutics, Inc. | 10.93M | -0.19% | 437,966 | - |
| 555 | CLRB | Cellectar Biosciences, Inc. | 10.80M | 11.40% | 3,288,266 | - |
| 556 | TSBX | Turnstone Biologics Corp. | 10.77M | -5.19% | 13,441 | - |
| 557 | ENSC | Ensysce Biosciences, Inc. | 10.74M | 1.60% | 30,714 | 4.42M |
| 558 | APLM | Apollomics, Inc. | 10.61M | -1.33% | 19,107 | 2.10M |
| 559 | BRTX | BioRestorative Therapies, Inc. | 10.45M | -2.58% | 9,640 | 377.00K |
| 560 | PHGE | BiomX Inc. | 10.18M | -9.68% | 80,516 | - |
| 561 | CANF | Can-Fite BioPharma Ltd. | 10.09M | -1.02% | 75,956 | 667.00K |
| 562 | KPRX | Kiora Pharmaceuticals, Inc. | 9.84M | 0.31% | 27,059 | 16.02M |
| 563 | EYEN | Eyenovia, Inc. | 9.62M | 1.17% | 7,393,841 | 31.83K |
| 564 | EVGN | Evogene Ltd. | 9.30M | 0.74% | 45,987 | 7.48M |
| 565 | INDP | Indaptus Therapeutics, Inc. | 9.30M | -2.78% | 13,863 | - |
| 566 | BCDA | BioCardia, Inc. | 9.22M | 2.11% | 14,543 | 71.00K |
| 567 | VIRX | Viracta Therapeutics, Inc. | 9.15M | 9.62% | 388,162 | - |
| 568 | KLTO | Klotho Neurosciences, Inc. | 9.12M | -1.31% | 31,361 | - |
| 569 | ICU | SeaStar Medical Holding Corporation | 9.02M | -1.94% | 94,695 | 68.00K |
| 570 | PPBT | Purple Biotech Ltd | 8.93M | 4.68% | 53,148 | - |
| 571 | CSCI | COSCIENS Biopharma Inc. | 8.52M | -0.39% | 1,570 | 4.83M |
| 572 | VRAX | Virax Biolabs Group Limited | 8.21M | 8.00% | 346,430 | 84.87K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 8.17M | 1.25% | 90,906 | 194.00K |
| 574 | DOMH | Dominari Holdings Inc. | 8.03M | 1.59% | 28,048 | 12.59M |
| 575 | MBIO | Mustang Bio, Inc. | 7.98M | -0.30% | 487,532 | - |
| 576 | CERO | CERo Therapeutics Holdings, Inc. | 7.97M | -5.53% | 14,277,976 | - |
| 577 | GNPX | Genprex, Inc. | 7.91M | 2.21% | 101,084 | - |
| 578 | ELAB | Elevai Labs Inc. | 7.77M | -1.17% | 297,765 | 2.45M |
| 579 | SNGX | Soligenix, Inc. | 7.18M | -3.06% | 50,777 | 364.18K |
| 580 | CDT | Conduit Pharmaceuticals Inc. | 6.68M | -25.44% | 16,050,233 | - |
| 581 | ADIL | Adial Pharmaceuticals, Inc. | 6.57M | -4.18% | 54,656 | - |
| 582 | VINC | Vincerx Pharma, Inc. | 6.48M | -6.81% | 1,101,100 | - |
| 583 | PRTG | Portage Biotech Inc. | 6.46M | -3.35% | 80,742 | - |
| 584 | GRI | GRI Bio, Inc. | 6.45M | -2.36% | 141,251 | - |
| 585 | PSTV | Plus Therapeutics, Inc. | 6.43M | - | 19,766 | 5.73M |
| 586 | EDSA | Edesa Biotech, Inc. | 6.42M | 6.99% | 3,405 | - |
| 587 | GLTO | Galecto, Inc. | 6.33M | 2.27% | 5,490 | - |
| 588 | GTBP | GT Biopharma, Inc. | 6.28M | 60.59% | 20,047,499 | - |
| 589 | CNSP | CNS Pharmaceuticals, Inc. | 6.28M | 1.11% | 2,170,597 | - |
| 590 | ABVC | ABVC BioPharma, Inc. | 6.22M | -3.11% | 62,152 | 509.79K |
| 591 | ALZN | Alzamend Neuro, Inc. | 6.19M | 2.70% | 80,778 | - |
| 592 | XBIO | Xenetic Biosciences, Inc. | 6.14M | -7.23% | 2,813 | 2.52M |
| 593 | COEP | Coeptis Therapeutics Holdings, Inc. | 5.88M | 1.13% | 62,447 | - |
| 594 | ADXN | Addex Therapeutics Ltd | 5.83M | -1.60% | 6,961 | 701.26K |
| 595 | HOTH | Hoth Therapeutics, Inc. | 5.63M | 0.77% | 60,360 | - |
| 596 | SYRS | Syros Pharmaceuticals, Inc. | 5.46M | 1.75% | 776,860 | 386.00K |
| 597 | BNOX | Bionomics Limited | 5.44M | 15.01% | 476,769 | - |
| 598 | ONVO | Organovo Holdings, Inc. | 5.18M | -6.28% | 150,486 | 103.00K |
| 599 | BPTH | Bio-Path Holdings, Inc. | 5.13M | -5.56% | 1,218,622 | - |
| 600 | MBRX | Moleculin Biotech, Inc. | 5.01M | - | 311,256 | - |
| 601 | EVAX | Evaxion Biotech A/S | 4.97M | -3.15% | 49,298 | 3.30M |
| 602 | PLRZ | Polyrizon Ltd. | 4.95M | -2.47% | 268,648 | - |
| 603 | CMND | Clearmind Medicine Inc. | 4.95M | 1.67% | 26,037 | - |
| 604 | ALLR | Allarity Therapeutics, Inc. | 4.66M | 6.05% | 327,405 | - |
| 605 | NCNA | NuCana plc | 4.63M | -2.60% | 59,052 | - |
| 606 | GLMD | Galmed Pharmaceuticals Ltd. | 4.51M | 1.55% | 13,049 | - |
| 607 | LIXT | Lixte Biotechnology Holdings, Inc. | 4.50M | 1.01% | 4,322 | - |
| 608 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 4.39M | -6.41% | 173,843 | 18.63K |
| 609 | OGEN | Oragenics, Inc. | 4.27M | -1.46% | 109,183 | - |
| 610 | APM | Aptorum Group Limited | 4.16M | 5.02% | 8,136 | - |
| 611 | SNPX | Synaptogenix, Inc. | 4.07M | -2.32% | 36,852 | - |
| 612 | SLXN | Silexion Therapeutics Corp | 4.02M | 2.89% | 83,614 | - |
| 613 | CHRO | Channel Therapeutics Corporation | 3.92M | 1.03% | 24,981 | - |
| 614 | PTIX | Protagenic Therapeutics, Inc. | 3.87M | -5.02% | 1,704,332 | - |
| 615 | SILO | Silo Pharma, Inc. | 3.81M | -3.19% | 26,458 | 72.10K |
| 616 | XRTX | XORTX Therapeutics Inc. | 3.80M | 2.57% | 2,373 | - |
| 617 | ATNF | 180 Life Sciences Corp. | 3.75M | 2.06% | 26,742 | - |
| 618 | LIPO | Lipella Pharmaceuticals Inc. | 3.72M | 17.94% | 260,342 | 483.53K |
| 619 | DWTX | Dogwood Therapeutics, Inc. | 3.71M | 19.08% | 58,295 | - |
| 620 | CELZ | Creative Medical Technology Holdings, Inc. | 3.65M | 0.97% | 8,891 | 11.00K |
| 621 | TNFA | TNF Pharmaceuticals, Inc. | 3.53M | -5.82% | 81,152 | - |
| 622 | ATXI | Avenue Therapeutics, Inc. | 3.45M | 1.88% | 43,572 | - |
| 623 | INM | InMed Pharmaceuticals Inc. | 3.43M | 13.55% | 14,209 | 4.96M |
| 624 | TOVX | Theriva Biologics, Inc. | 3.37M | 6.09% | 83,481 | - |
| 625 | HEPA | Hepion Pharmaceuticals, Inc. | 3.34M | -1.94% | 10,361 | - |
| 626 | KTTA | Pasithea Therapeutics Corp. | 3.33M | - | 4,479 | - |
| 627 | NLSP | NLS Pharmaceutics AG | 3.27M | 3.42% | 37,467 | - |
| 628 | AZTR | Azitra, Inc. | 3.13M | -1.23% | 68,269 | 97.50K |
| 629 | TCRT | Alaunos Therapeutics, Inc. | 3.12M | -0.51% | 6,377 | 7.00K |
| 630 | ENVB | Enveric Biosciences, Inc. | 3.11M | -3.85% | 66,974 | - |
| 631 | THAR | Tharimmune, Inc. | 3.09M | 0.48% | 59,615 | - |
| 632 | ARTL | Artelo Biosciences, Inc. | 3.07M | 0.26% | 14,842 | - |
| 633 | TTNP | Titan Pharmaceuticals, Inc. | 3.02M | -2.37% | 41,571 | 3.00K |
| 634 | ONCO | Onconetix, Inc. | 3.01M | 4.55% | 867,192 | 1.87M |
| 635 | ADTX | Aditxt, Inc. | 2.99M | 12.84% | 4,706,618 | 212.11K |
| 636 | ENTO | Entero Therapeutics, Inc. | 2.92M | -2.38% | 24,790 | - |
| 637 | QLGN | Qualigen Therapeutics, Inc. | 2.90M | 1.03% | 2,729 | - |
| 638 | WINT | Windtree Therapeutics, Inc. | 2.89M | 0.41% | 246,183 | - |
| 639 | SCNI | Scinai Immunotherapeutics Ltd. | 2.86M | -2.33% | 1,496 | 452.00K |
| 640 | ZVSA | ZyVersa Therapeutics, Inc. | 2.81M | 5.26% | 58,986 | - |
| 641 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.80M | -2.64% | 146,727 | - |
| 642 | PCSA | Processa Pharmaceuticals, Inc. | 2.69M | -3.06% | 79,534 | - |
| 643 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.67M | -7.94% | 1,453,637 | 462.61K |
| 644 | MTNB | Matinas BioPharma Holdings, Inc. | 2.66M | -4.13% | 65,506 | - |
| 645 | DRMA | Dermata Therapeutics, Inc. | 2.49M | 12.96% | 1,201,005 | - |
| 646 | NBY | NovaBay Pharmaceuticals, Inc. | 2.46M | -5.17% | 78,427 | 13.84M |
| 647 | PALI | Palisade Bio, Inc. | 2.39M | 2.76% | 82,802 | - |
| 648 | PBM | Psyence Biomedical Ltd. | 2.37M | -25.13% | 1,419,158 | - |
| 649 | BDRX | Biodexa Pharmaceuticals Plc | 2.26M | -2.63% | 15,184 | 104.90K |
| 650 | SLRX | Salarius Pharmaceuticals, Inc. | 2.23M | - | 43,378 | - |
| 651 | APVO | Aptevo Therapeutics Inc. | 2.21M | 0.19% | 41,686 | - |
| 652 | PHIO | Phio Pharmaceuticals Corp. | 2.20M | 18.42% | 10,401,766 | - |
| 653 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.01M | 0.66% | 184,667 | 74.00K |
| 654 | RNAZ | TransCode Therapeutics, Inc. | 1.90M | -3.46% | 44,749 | - |
| 655 | VRPX | Virpax Pharmaceuticals, Inc. | 1.71M | 6.06% | 408,307 | - |
| 656 | SCPX | Scorpius Holdings, Inc. | 1.39M | -5.77% | 174,984 | 10.04M |
| 657 | REVB | Revelation Biosciences, Inc. | 1.29M | 1.73% | 233,434 | - |
| 658 | MTEM | Molecular Templates, Inc. | 974.41K | -7.50% | 1,594,184 | 25.47M |
| 659 | SPRC | SciSparc Ltd. | 717.22K | -6.26% | 395,542 | 1.75M |
| 660 | TCBP | TC Biopharm (Holdings) Plc | 362.27K | 0.15% | 451,877 | - |